These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30225179)

  • 21. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
    Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G
    J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
    Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
    Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Study of Quinolone Resistance Determining Regions of
    Zaki MES; Abou ElKheir N; Mofreh M
    Open Microbiol J; 2018; 12():116-122. PubMed ID: 29785218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
    J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil.
    Minarini LA; Darini AL
    Braz J Microbiol; 2012 Oct; 43(4):1309-14. PubMed ID: 24031957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.
    Song J; Qiao Y; Kong Y; Ruan Z; Huang J; Song T; Zhang J; Xie X
    J Med Microbiol; 2015 Nov; 64(11):1315-1320. PubMed ID: 26243148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.
    Giraud E; Brisabois A; Martel JL; Chaslus-Dancla E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2131-7. PubMed ID: 10471553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India.
    Balakrishnan S; Antony PX; Mukhopadhyay HK; Pillai RM; Thanislass J; Padmanaban V; Srinivas MV
    Vet World; 2016 Jul; 9(7):705-9. PubMed ID: 27536030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.
    Weigel LM; Anderson GJ; Tenover FC
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2582-7. PubMed ID: 12121936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lin JN; Lai CH; Yang CH; Huang YH
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31466280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011.
    Qin T; Bi R; Fan W; Kang H; Ma P; Gu B
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2037-2045. PubMed ID: 27620866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana.
    Acheampong G; Owusu M; Owusu-Ofori A; Osei I; Sarpong N; Sylverken A; Kung HJ; Cho ST; Kuo CH; Park SE; Marks F; Adu-Sarkodie Y; Owusu-Dabo E
    BMC Infect Dis; 2019 Oct; 19(1):898. PubMed ID: 31660876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics.
    Mirza HC; Tuncer Ö; Ölmez S; Şener B; Tuğcu GD; Özçelik U; Gürsoy NC; Otlu B; Büyükçam A; Kara A; Sancak B
    Microb Drug Resist; 2018; 24(6):816-821. PubMed ID: 29227188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of quinolone resistance in Staphylococcus aureus.
    Tanaka M; Wang T; Onodera Y; Uchida Y; Sato K
    J Infect Chemother; 2000 Sep; 6(3):131-9. PubMed ID: 11810552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.